Home > Boards > US OTC > Medical - Healthcare >

Avinger Inc (AVGR)

AVGR RSS Feed
Add AVGR Price Alert      Hide Sticky   Hide Intro
Moderator: Golden_Cross
Search This Board: 
Last Post: 5/20/2019 1:33:08 PM - Followers: 54 - Board type: Free - Posts Today: 0

Avinger, Inc. (AVGR) is a commercial stage medical device company that designs and develops the first ever image guided,catheterbased  system  for  the  diagnosis  and  treatment  of  patients  with  peripheral  artery  disease  (PAD).  The  Sage  Group projected that over 21 million people in the U.S. alone will suffer from PAD by 2020. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusio (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger also markets the Wildcat and Kittycat2 endovascular catheters for CTO crossing. Avinge's Lumivascular and
endovascular treatment are FDA cleared, CE Marked, and commercially available in the U.S. and select international markets. The Company has five new products in the pipeline for future revenue opportunities, each representing ~$100 to ~$300 million market opportunities. Avinger's Lumivascular platform is the only technology that offers real time visualization of the inside of the artery during PAD treatment via optical coherence tomography (OCT), a high resolution, light based, radiation free imaging technology. The Lumivascular platform provides physicians a clear picture inside the artery during treatment, enabling them to better differentiate between plaque and healthy arterial structures while avoiding damage to healthy portions of an artery. It significantly improves procedural safety. According to MarketsandMarkets, the peripheral vascular device global market will reach$12.6 billion by 2022. Global Market Estimates projects that the worldwide CTO devices market will reach $1.8 billion by 2025.

Avinger's Management is committed to lowering costs, revamping products, and increasing revenue across the board. Avingerhas 120 patents and pending applications.  Avinger is based in Redwood City, California

Press Releases

Date   Headline
Jan 28, 2019 Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
Dec 19, 2018 Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study
Dec 13, 2018 Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
Dec 06, 2018 Avinger Announces Commercial Launch in Australia
Nov 15, 2018 Avinger Announces Successful Treatment of First Patients Globally with Pantheris SV, a New Image-Guided Atherectomy Device Designed to Treat Smaller Vessels
Nov 13, 2018 Avinger Provides Third Quarter 2018 Shareholder Update
Nov 07, 2018 Avinger to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2018
Nov 05, 2018 Avinger to Announce Third Quarter 2018 Financial Results on November 13, 2018
Nov 01, 2018 Avinger Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Oct 30, 2018 Avinger Announces Pricing of $10 Million Underwritten Public Offering
 

This just got full FDA approval!
https://youtu.be/7qnTiFOldhA

AVGR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVGR News: Statement of Changes in Beneficial Ownership (4) 05/16/2019 01:26:00 PM
AVGR News: Statement of Changes in Beneficial Ownership (4) 05/16/2019 01:22:59 PM
AVGR News: Statement of Changes in Beneficial Ownership (4) 05/16/2019 01:22:01 PM
AVGR News: Quarterly Report (10-q) 05/08/2019 04:35:36 PM
AVGR News: Current Report Filing (8-k) 05/08/2019 04:07:24 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#748   Must be worth 3.00 at this point breezy1 05/20/19 01:33:08 PM
#747   AVGR Daily Chart; Ready for a bullish cross Golden_Cross 05/17/19 07:08:12 PM
#746   * * $AVGR Video Chart 05-06-2019 * * ClayTrader 05/06/19 05:23:54 PM
#745   * * $AVGR Video Chart 05-03-2019 * * ClayTrader 05/03/19 05:30:41 PM
#744   AVGR Daily Chart Golden_Cross 04/29/19 06:31:49 PM
#743   * * $AVGR Video Chart 04-25-2019 * * ClayTrader 04/25/19 05:37:20 PM
#742   MDT appears to not have Avinger’s tech breezy1 04/25/19 12:27:36 AM
#741   AVGR Daily Chart: Nice move today. Golden_Cross 04/24/19 06:07:15 PM
#740   or Shorts covering, still back to .50 Pyramid2 04/24/19 05:26:02 PM
#739   * * $AVGR Video Chart 04-24-2019 * * ClayTrader 04/24/19 04:35:17 PM
#738   There was proxy statement issued on April 5 Ryoko 04/24/19 01:28:36 PM
#737   Ryoko. Is there a news release on the Aitkenresearch 04/24/19 12:40:29 PM
#736   Nothing, looks like another pump and dump to me Pyramid2 04/24/19 10:46:53 AM
#735   nice POP, any catalyst? [SMART MONEY] 04/24/19 10:43:40 AM
#734   Curious run on AVGR this morning. Insiders got Ryoko 04/24/19 10:34:24 AM
#733   $AVGR Daily Chart Golden_Cross 04/20/19 09:37:02 AM
#732   Block trades don't mean much, we will see Full Contact Yoga 04/17/19 07:01:34 PM
#731   Pyramid2 04/17/19 06:22:21 PM
#730   I Believe the word is getting out on Pyramid2 04/17/19 06:22:14 PM
#729   I've been bouncing it off .60ish since Full Contact Yoga 04/17/19 05:41:31 PM
#728   someone bought 378,300 shares in AHhttps://www.nasdaq.com/symbol/avgr/after-hours Pyramid2 04/17/19 04:32:10 PM
#727   hope those stuck holding took the opportunity to Full Contact Yoga 04/17/19 01:52:57 PM
#726   Old news. The patent was awarded 2 weeks ago. Ryoko 04/17/19 01:52:35 PM
#725   Should Be Go Time with that News..... jobilly 04/17/19 12:32:31 PM
#724   News: $AVGR Avinger Announces Issuance of New U.S. whytestocks 04/17/19 11:30:44 AM
#723   Sounds about right. Quick trades possible, but Full Contact Yoga 04/16/19 10:53:43 AM
#722   Re-read my post. This is a POS Full Contact Yoga 04/16/19 10:46:17 AM
#721   There's an old maxim I learned over the Ryoko 04/16/19 10:43:28 AM
#720   Let me ask you something? Are you invested RickMG92 04/16/19 10:42:28 AM
#719   100% irrelevant, old, and priced in. This Full Contact Yoga 04/16/19 10:20:25 AM
#718   Maybe after RS, but zero chance of testing Full Contact Yoga 04/16/19 10:17:48 AM
#717   Everything you've stated greatly helps the company. Full Contact Yoga 04/16/19 09:52:17 AM
#716   https://charts.stocktwits.com/production/original_160803072.PNG guchu 04/16/19 12:32:20 AM
#713   The correction was from short term trades from breezy1 04/14/19 05:43:56 PM
#712   https://www.medtechdive.com/news/avingers-image-guided-device-for-pad-gets-fda-n Pyramid2 04/14/19 05:36:35 PM
#711   I’m voting against it, they have clearance now Dasher95 04/14/19 04:08:11 AM
#710   Everyone please, please, please read this! RickMG92 04/14/19 03:55:02 AM
#709   Based on this, does this not look like RickMG92 04/14/19 01:02:54 AM
#708   There are 3,000,000 PAD cases in the US Pyramid2 04/13/19 05:45:50 PM
#707   What is the “Shelf Offering”? What does that RickMG92 04/13/19 04:25:38 PM
#706   When you say the “shelf offering will likely RickMG92 04/13/19 04:21:10 PM
#705   There's not much of a choice to do Ryoko 04/13/19 11:35:09 AM
#704   Shareholders will vote whether or not to authorize Pyramid2 04/13/19 10:08:21 AM
#703   Sorry wrong post. Lol. Aitkenresearch 04/12/19 09:36:51 PM
#702   TPL and allocation of resources. I use TPL as Aitkenresearch 04/12/19 09:35:54 PM
#701   AVGR Daily Chart: Very conflicting IMO Golden_Cross 04/12/19 08:45:13 PM
#700   I'm a little surprised the price mostly held Ryoko 04/12/19 06:54:52 PM
#699   * * $AVGR Video Chart 04-12-2019 * * ClayTrader 04/12/19 04:06:17 PM
#698   * * $AVGR Video Chart 04-11-2019 * * ClayTrader 04/11/19 04:27:14 PM
#697   nice trade off the .6 bounce, still a Full Contact Yoga 04/11/19 11:53:16 AM
PostSubject